oid_920e90a8-d5ea-ef11-be20000d3ab07f94_CYCLE_LOGO2.png

Cyclana Bio

Drug Discovery

  • Funding stage: Pre-seed
  • Technology type: Any
  • Cambridge
Phone
+447880894277
Membership category
Corporate Introductory

Cycle Therapeutics Ltd, 82 Huntingdon Road, Cambridge, CB3 0HH, United Kingdom

Cyclana Bio at a glance

A tissue-level multidisciplinary approach to curing Endometriosis.

About Cyclana Bio

Cycle Therapeutics is a team led by researchers in computational and tissue-level biology who are creating a different model for scientific discovery, centred around human tissue-level data. Our main focus is on improving treatments in women’s health, harnessing the breadth of information we get every month from menstrual fluid. We are collecting multi-omic and clinical data to generate the first tissue-level disease database. We are pairing this with a unique methodology for modelling tissue level disease ex vivo with our high throughput hydrogel screening assays for target validation. Overall, we are building a therapeutic research platform to identify new therapeutic avenues for inflammatory and autoimmune conditions such as endometriosis. 

Therapeutic area(s)

Articles Cyclana Bio has contributed to